Pharma-Bio Serv, Inc. (PBSV)
USD 0.55
(0.0%)
USD 0.55
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 16.97 Million | 19.39 Million | 20.11 Million | 21.56 Million | 19.5 Million | 17.79 Million |
| Cost of Revenue | 11.91 Million | 14.51 Million | 14.75 Million | 14.89 Million | 13.33 Million | 12.11 Million |
| Gross Profit | 5.06 Million | 4.88 Million | 5.35 Million | 6.66 Million | 6.17 Million | 5.68 Million |
| Operating Expenses | 3.94 Million | 3.7 Million | 9.21 Million | 4.44 Million | 4.47 Million | 4.59 Million |
| Selling, General and Administrative Expenses | 3.94 Million | 3.7 Million | 9.21 Million | 4.44 Million | 4.47 Million | 4.59 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 13.41 Thousand | 1.97 Million | 64.46 Thousand | 526.56 Thousand | 435.52 Thousand |
| Cost and Expenses | 15.85 Million | 18.22 Million | 23.96 Million | 19.33 Million | 17.81 Million | 16.7 Million |
| Operating Income | 1.11 Million | 1.17 Million | -3.85 Million | 2.22 Million | 1.69 Million | 1.08 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 377.3 Thousand | 181.67 Thousand | 213.24 Thousand | 239.08 Thousand | 135.99 Thousand | 2.78 Million |
| Earnings before Tax | 1.68 Million | 1.18 Million | -1.87 Million | 2.29 Million | 2.22 Million | 1.52 Million |
| Net Income | 1.31 Million | 1 Million | -2.08 Million | 2.05 Million | 2.08 Million | 1.27 Million |
| Earnings Per Share Basic | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 | 0.06 |
| Earnings Per Share Diluted | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 | 0.06 |
| Weighted Average Shares Outstanding | 22.97 Million | 23 Million | 23.02 Million | 23 Million | 23.05 Million | 23.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.99 Million | 23.03 Million | 23.02 Million | 23.04 Million | 23.11 Million | 23.09 Million |
| Gross Margin | 0.30 | 0.25 | 0.27 | 0.31 | 0.32 | 0.32 |
| EBIT Margin | 0.08 | 0.06 | -0.19 | 0.11 | 0.09 | 0.07 |
| Profit Margin | 0.08 | 0.05 | -0.10 | 0.10 | 0.11 | 0.07 |
| EBITDA | 1.31 Million | 1.22 Million | -3.78 Million | 2.31 Million | 1.79 Million | 1.16 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | -0.19 | 0.10 | 0.09 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.41 Million | 2.37 Million | 2.38 Million | 3.59 Million | 16.97 Million | 4.57 Million |
| Cost of Revenue | 1.78 Million | 1.75 Million | 1.84 Million | 2.66 Million | 11.91 Million | 3.02 Million |
| Gross Profit | 635.38 Thousand | 618.47 Thousand | 535.6 Thousand | 929.8 Thousand | 5.06 Million | 1.55 Million |
| Operating Expenses | 1.01 Million | 931.85 Thousand | 973.9 Thousand | 981.57 Thousand | 3.94 Million | 1.08 Million |
| Selling, General and Administrative Expenses | 1.01 Million | 931.85 Thousand | 973.9 Thousand | 981.57 Thousand | - | 1.08 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 91.59 Thousand | 120.73 Thousand | 180.52 Thousand | 3930.00 | 570.07 Thousand | 126.98 Thousand |
| Cost and Expenses | 2.79 Million | 2.69 Million | 2.81 Million | 3.64 Million | 15.85 Million | 4.11 Million |
| Operating Income | -381.78 Thousand | -313.38 Thousand | -438.3 Thousand | -51.76 Thousand | 1.11 Million | 460.46 Thousand |
| Interest Expense | - | - | - | 439.16 Thousand | - | - |
| Income Tax Expense | 19 Thousand | 21.17 Thousand | 12.94 Thousand | -687.00 | 377.3 Thousand | 61.2 Thousand |
| Earnings before Tax | -290.19 Thousand | -192.63 Thousand | -257.77 Thousand | -47.83 Thousand | 1.68 Million | 587.45 Thousand |
| Net Income | -309.19 Thousand | -213.81 Thousand | -270.71 Thousand | -47.14 Thousand | 1.31 Million | 526.24 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.00 | - | 0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.00 | - | 0.02 |
| Weighted Average Shares Outstanding | 22.96 Million | 22.96 Million | 22.96 Million | 22.96 Million | 22.97 Million | 22.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.96 Million | 22.96 Million | 22.98 Million | 22.96 Million | 22.99 Million | 22.98 Million |
| Gross Margin | 0.26 | 0.26 | 0.23 | 0.26 | 0.30 | 0.34 |
| EBIT Margin | -0.14 | -0.11 | -0.16 | 0.03 | - | 0.10 |
| Profit Margin | -0.13 | -0.09 | -0.11 | -0.01 | 0.08 | 0.11 |
| EBITDA | -337.38 Thousand | -268.7 Thousand | -392.72 Thousand | 101.86 Thousand | - | 471.86 Thousand |
| Earnings Before Tax Margin | -0.16 | -0.13 | -0.18 | -0.01 | 0.07 | 0.10 |
GAEL
ILU
DNZOF
WBC
CIADF
SOUTHBANK